arrow
Á

Ángela Cano

instituto maimónides de investigación biomédica de córdoba (imibic)
H指数:19
被引数:1,179

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Compassionate Use of Encapsulated MKB-01 Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection: A Single-Center Experience

同情性使用封装的MKB-01粪菌移植治疗复发性Clostridioides difficile感染:一项单中心经验

2025-09-270
OAAI
Incidence, clinical and genomic trends of hospital- and Non-hospital-onset KPC-producing Klebsiella pneumoniae infections before and during the COVID-19 era: a ten-year interrupted time series study

医院获得与非医院获得产KPC型肺炎克雷伯菌感染在COVID-19时代前后的发病率、临床及基因组趋势:一项为期十年的中断时间序列研究

2025-08-250
PRE
Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

多药耐药革兰阴性杆菌感染在成年实体器官移植受者中的管理:GESITRA-IC/SEIMC、CIBERINFEC和SET指南更新。

2025-07-010
PRE
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3 noninferiority trial

西班牙低风险肺移植受者中免疫指导性巨细胞病毒疾病预防的安全性与有效性:一项多中心、开放标签、随机、III期非劣效性试验

2025-05-010
PRE
Quantifying Gamma-Interferon from CMV-Specific CD8+T Cells Defines Protection Against Clinically Significant CMV Infection in Solid Organ Transplant Recipients: The Quanti-CMV Score

通过定量CMV特异性CD8+T细胞中的γ-干扰素来定义实体器官移植受者临床显著CMV感染的防护作用:Quanti-CMV评分

2025-03-040
OA
Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae : An observational study

大剂量静脉注射磷霉素治疗KPC产碳青霉烯酶肺炎克雷伯菌尿路感染的疗效观察

2025-03-010
OAAI
Invasive aspergillosis in liver transplant recipients in the current era
2024-11-011
PRE
Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital

抗菌药物管理计划对高流行医院耐碳青霉烯类肺炎克雷伯菌感染发生率的长期临床和生态影响

2024-08-231
OA
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)

碳青霉烯类耐药肠杆菌引起的感染的可归因死亡率: 一项前瞻性、多国病例-对照匹配队列研究 (EURECA) 的结果

2024-02-0111
OA
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control- control study (EURECA)

耐碳青霉烯类肠杆菌感染的危险因素: 一项国际配对病例对照研究 (EURECA)

2023-03-0131
OAAI
Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study
2022-12-260
PRE
Proof-of-concept study to quantify changes in intestinal loads of KPC-producing Klebsiella pneumoniae in colonised patients following selective digestive decontamination with oral gentamicin

概念验证研究,用于量化口服庆大霉素进行选择性消化净化后定植患者中产生KPC的肺炎克雷伯菌的肠道负荷变化

2022-09-013
OAAI
Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients

在定植患者的前瞻性队列中,肠道微生物群中产生KPC的肺炎克雷伯菌的相对负荷的预后意义

2022-08-315
OAAI
Association between rectal colonisation by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study

产碳青霉烯酶肺炎克雷伯菌直肠定植与死亡率的关系: 一项前瞻性观察性研究

2022-06-018
OAAI
Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients

住院患者肺炎克雷伯菌产碳青霉烯酶肺炎克雷伯菌感染的定植时机与发病风险的关系

2022-04-2710
OAAI
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial

7天与14天疗程的抗生素治疗肠细菌引起的血流感染: 一项随机对照试验

2022-04-0173
OA
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial
2021-06-2240
OA
Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis

抗菌药物管理计划对碳青霉烯类耐药革兰阴性杆菌发生率的影响: 一项间断的时间序列分析

2021-05-1615
OAAI